MuraliJanakiramMDMS

PubMed

• Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients ...
  Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Martin Schoen
  JNCI Cancer Spectrum. 2024-11-01
• 1 citations
  Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy.
  Scott R Goldsmith, Geoffrey Shouse, F Lennie Wong, Alysia Bosworth, Aleksi Iukuridze
  Transplantation and Cellular Therapy. 2024-09-01
• 1 citations
  Targeting cancer stem cells in multiple myeloma.
  Emine Gulsen Gunes, Metin Gunes, Jianhua Yu, Murali Janakiram
  Trends in Cancer. 2024-08-01

Abstracts/Posters

• Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)
  Murali Janakiram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• S-Phase Progression of North American ATLL Cells Is Critically Regulated By the Proto-Oncogene BCL6 and Targetable By PARP Inhibition
  Murali Janakiram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multip...
  Murali Janakiram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort
  Murali Janakiram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• The Rising Number of Adult T Cell Leukemia Lymphoma (ATLL) Cases in Non-Hispanic Blacks and Its Association with Poor Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Causes and Predictors of Early Mortality in HIV-Positive and HIV-Negative Patients with Diffuse Large B-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Stagin... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all